Key Takeaways
- Rocket Lab shares have declined 8% year-to-date, currently priced at $64.26, significantly below the 12-month peak of $151.00
- Analysts maintain Strong Buy consensus with $108.88 average target price, suggesting 69% potential appreciation
- Cantor Fitzgerald upgraded its target to $122, highlighting strong Q2 performance and Neutron development progress
- BofA adjusted target downward to $110 from $115 while maintaining Buy rating, emphasizing $2.36B order backlog
- Saudi Central Bank increased RKLB holdings by over 100% in Q2; ARK Invest added more than 705,000 shares in recent trades
Shares of Rocket Lab (RKLB) began Monday’s session at $64.26, marking an approximately 8% decline from the year’s opening price. The aerospace company has experienced a substantial 49% contraction over the trailing three-month period and remains well beneath its 12-month pinnacle of $151.00.
Yet the recent downturn hasn’t shaken analyst confidence. The Street maintains a Strong Buy consensus rating on RKLB shares, comprising 13 Buy recommendations alongside four Hold ratings. With an average target of $108.88, analysts are projecting approximately 69% upside from current levels.
Cantor Fitzgerald’s Andres Sheppard elevated his target to $122 from $96 while reaffirming his Buy stance. His bullish outlook stems from impressive Q2 revenue results and management’s reassurance that the Neutron rocket development timeline remains intact for its inaugural launch later this year.
Sheppard characterized Rocket Lab’s pending Iridium acquisition as “transformational,” projecting the merged entity will achieve double the annual revenue upon deal completion.
Neutron Development Timeline Critical for Growth Trajectory
The Neutron rocket represents the cornerstone of Rocket Lab‘s expansion strategy. This reusable medium-lift launch system would enable the company to compete in a substantially larger market segment than its existing Electron rocket currently addresses.
Nevertheless, execution risks persist. Industry reports indicate Neutron’s maiden flight might be postponed until 2027, potentially delaying significant revenue generation. Bank of America’s Ronald Epstein identified the development schedule as “a key aspect to watch,” acknowledging that while a Q4 2026 demonstration flight remains feasible, the timeline presents considerable challenges.
Epstein reduced his target to $110 from $115, adjusting for increased share dilution, while maintaining his Buy recommendation. He emphasized Rocket Lab’s “strong positioning across launch and space systems capabilities” alongside the robust $2.36 billion contract backlog encompassing over 90 scheduled launches.
Large Investors Accumulate Shares
Among institutional stakeholders, Saudi Central Bank dramatically expanded its RKLB position during Q2, purchasing 18,670 additional shares to elevate its total holdings to 36,415 shares worth approximately $3.7 million. Meanwhile, ARK Invest acquired over 705,000 shares during two consecutive trading sessions.
Institutional entities and hedge funds control 71.78% of outstanding RKLB shares.
This accumulation stands in contrast to insider disposal activity. CFO Adam Spice divested 140,157 shares on September 2nd at $62.63 per share, generating approximately $8.78 million in proceeds. The sale occurred under a predetermined Rule 10b5-1 trading arrangement.
For Q2, Rocket Lab delivered revenue of $234.07 million, surpassing Wall Street’s $231.62 million projection. However, earnings per share of -$0.08 fell short of the -$0.06 consensus forecast. The company continues operating at a loss, with full-year EPS anticipated at -$0.20.
A potentially favorable development emerged last week when Planet Labs highlighted increasing capacity constraints within SpaceX’s rideshare program, potentially driving additional customers toward alternative launch providers including Rocket Lab.
Additionally, the company achieved its 94th consecutive successful mission and maintains 16 confirmed launches scheduled through 2030.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
